Literature DB >> 18178468

Treatment of the incompetent great saphenous vein by endovenous radiofrequency powered segmental thermal ablation: first clinical experience.

Thomas Michael Proebstle1, Bernadette Vago, Jens Alm, Oliver Göckeritz, Christian Lebard, Olivier Pichot.   

Abstract

BACKGROUND: Radiofrequency ablation of saphenous veins has proven efficacy with an excellent side effect profile but has the disadvantage of a lengthy pullback procedure. This article reports a new endovenous catheter for radiofrequency-powered segmental thermal ablation (RSTA) of incompetent great saphenous veins (GSVs).
METHODS: A prospective, nonrandomized, multicenter study was conducted to evaluate the safety, feasibility, and early clinical outcomes of RSTA of the GSV.
RESULTS: A total of 194 patients with 252 GSVs with an average diameter of 5.7 +/- 2.2 mm (range, 2.0 to 18.0 mm) received RSTA under tumescent local anesthesia. In 58 patients (29.9%), bilateral treatment (average length treated, 36.7 +/- 10.8 cm) was done. The average total endovenous procedure time was 16.4 +/- 8.2 minutes, and the average total energy delivery time was 2.2 +/- 0.6 minutes. The corresponding endovenous fluence equivalent delivered to the proximal 7-cm vein segment was 82 +/- 25 J/cm(2) (range, 38 to 192). Follow-up at 3 days, 3 months, and 6 months was obtained from 250, 164, and 62 limbs, respectively. Occlusion rates were 99.6% for all three follow-up dates according to life-table analysis. The average Venous Clinical Severity Score was 3.4 +/- 1.2 at 3 days, 0.9 +/- 1.6 at 3 months, and 1.5 +/- 1.8 at 6 months compared with 3.9 +/- 2.0 at baseline.
CONCLUSION: Radiofrequency segmental thermal ablation is feasible, safe, and well tolerated.

Entities:  

Mesh:

Year:  2008        PMID: 18178468     DOI: 10.1016/j.jvs.2007.08.056

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  26 in total

Review 1.  [Diagnosis and treatment of varicose veins: part 2: therapeutic procedures and results].

Authors:  H Nüllen; T Noppeney
Journal:  Chirurg       Date:  2010-12       Impact factor: 0.955

2.  [Treatment of primary varicosis].

Authors:  T Noppeney; H Nüllen
Journal:  Internist (Berl)       Date:  2010-03       Impact factor: 0.743

Review 3.  The state of the art of endothermal ablation.

Authors:  Renate R van den Bos; Thomas M Proebstle
Journal:  Lasers Med Sci       Date:  2014-03       Impact factor: 3.161

4.  Utility of the Ginza forceps for superficial phlebectomy during endovenous laser ablation of the great saphenous vein.

Authors:  Takeshi Baba; Takao Ohki; Yuji Kanaoka; Koji Maeda; Kenjirou Kaneko; Masayuki Hara; Kota Shukuzawa; Soichiro Fukushima
Journal:  Surg Today       Date:  2017-04-07       Impact factor: 2.549

5.  [Endovenous thermal ablation of saphenous varicosis].

Authors:  A Ladwig; H Riebe; F Pannier; S Schuller-Petrovic; M Jünger
Journal:  Hautarzt       Date:  2012-08       Impact factor: 0.751

6.  Radiofrequency ablation of the great saphenous vein with the ClosureFAST™ procedure: mid-term experience on 400 patients from a single centre.

Authors:  Valerio S Tolva; Lea V Cireni; Paolo G Bianchi; Almarosa Lombardo; Guido C Keller; Renato M Casana
Journal:  Surg Today       Date:  2012-08-30       Impact factor: 2.549

7.  [Foam sclerotherapy. Uses and indications in dermatology and phlebology].

Authors:  M Heck; J Faulhaber; F X Breu; S W Schneider
Journal:  Hautarzt       Date:  2012-06       Impact factor: 0.751

8.  Temperature profiles of 980- and 1,470-nm endovenous laser ablation, endovenous radiofrequency ablation and endovenous steam ablation.

Authors:  W S J Malskat; M A L Stokbroekx; C W M van der Geld; T E C Nijsten; R R van den Bos
Journal:  Lasers Med Sci       Date:  2013-11-30       Impact factor: 3.161

9.  Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-02-01

10.  Endovenous radiofrequency ablation: no value in short-term duplex ultrasound follow-up.

Authors:  M Broe; F M Shaikh; A Leahy
Journal:  Ir J Med Sci       Date:  2014-09-14       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.